Czechia· CZ-0271887
AQUIPTA
A atogepant product containing atogepant, registered in Czechia by AbbVie Deutschland GmbH & Co.KG, Ludwigshafen. The same ATC class is registered in 16 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Atogepant is registered in 16 of 19 countries.
Countries holding a registration under ATC N02CD07 (atogepant), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 11 of them publish a price we can compare per daily dose
Atogepant · ATC N02CD07
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of atogepant costs, country by country.
Normalised to the WHO defined daily dose (60 mg), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Atogepant · price per daily dose (60 mg)
USD · FX 28 Sept 2026
- IT Italy$96.51
- CH Switzerland$95.15
The record
At a glance
SÚKL (Czech Republic)- Active substance
- ATOGEPANT
- Manufacturer
- AbbVie Deutschland GmbH & Co.KG, Ludwigshafen
- Country
- Czechia (CZ)
- ATC code
- N02CD07
- ATC class
- Atogepant
- Defined daily dose
- 60 mg, O
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- cz_kod_sukl027188728CZK 12209.62
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Atogepant in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandAquipta
- SpainAQUIPTA 60 MG COMPRIMIDOSAbbvie Deutschland Gmbh & Co. Kg
- FinlandAQUIPTAAbbVie Deutschland GmbH&Co.KG
- FranceAQUIPTA 60 mg, compriméABBVIE DEUTSCHLAND (ALLEMAGNE)
- United KingdomAquipta 60mg tabletsAbbVie Ltd
- IrelandAQUIPTA 60 mg tabletsAbbVie Deutschland GmbH & Co. KG
- IcelandAquiptaAbbVie Deutschland GmbH & Co. KG
- NetherlandsAQUIPTA 60 mg tablettenAbbVie Deutschland GmbH & Co. KG
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Aquipta
- Iceland · Aquipta
- Liechtenstein · Aquipta
- Norway · Aquipta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/21fbea25-a706-4509-b88b-9e4a6ad347a7 GET /v1/drugs/21fbea25-a706-4509-b88b-9e4a6ad347a7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "TBL NOB",
"source": "sukl",
"strength": "60MG",
"pack_size": "28",
"substance": "ATOGEPANT",
"cz_kod_sukl": "0271887",
"product_type": "CH",
"substance_codes": "21305",
"registration_state": "R",
"registration_number": "EU/1/23/1750/003"
}See everything about atogepant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.